Franklin Street Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-10,450
| Closed | -$735K | – | 176 |
|
|
2016
Q4 | $735K | Sell |
10,450
-50
| -0.5% | -$3.52K | 0.13% | 106 |
|
|
2016
Q3 | $745K | Sell |
10,500
-790
| -7% | -$56.1K | 0.14% | 110 |
|
|
2016
Q2 | $552K | Sell |
11,290
-145
| -1% | -$7.09K | 0.1% | 125 |
|
|
2016
Q1 | $724K | Sell |
11,435
-20
| -0.2% | -$1.27K | 0.14% | 118 |
|
|
2015
Q4 | $1.29M | Hold |
11,455
| – | – | 0.25% | 103 |
|
|
2015
Q3 | $1.1M | Sell |
11,455
-510
| -4% | -$49.1K | 0.22% | 110 |
|
|
2015
Q2 | $1.23M | Sell |
11,965
-410
| -3% | -$42K | 0.22% | 106 |
|
|
2015
Q1 | $768K | Hold |
12,375
| – | – | 0.14% | 124 |
|
|
2014
Q4 | $543K | Sell |
12,375
-2,550
| -17% | -$112K | 0.1% | 129 |
|
|
2014
Q3 | $845K | Sell |
14,925
-800
| -5% | -$45.3K | 0.16% | 125 |
|
|
2014
Q2 | $706K | Buy |
15,725
+1,525
| +11% | +$68.5K | 0.13% | 147 |
|
|
2014
Q1 | $694K | Buy |
+14,200
| New | +$694K | 0.14% | 150 |
|